But FDA agreed to convene the panel of outside advisers after ALS patients and advocates submitted a 30, 000-signature petition seeking a public meeting.In the last year, the FDA has approved two new drugs for ALS, after a nearly 20-year drought of new options.... The approvals followed intense lobbying by advocacy groups.... Approving one like this would get in the way of that, ” said Dr....